Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frusemide–allopurinol interaction study in gout
ACTRN12609000529246Phase 4Completed
- Sponsor
- Lisa Stamp
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of allopurinol and furosemide in gout (6 arms), sponsored by Lisa Stamp. Primary endpoints: Change in serum urate concentration, Change in plasma oxypurinol/allopurinol concentration and 1 more. Started Jul 2009; status: completed.
02
Drugs
allopurinolfurosemide
03
Conditions
gout
Beyond the preview
Go deeper on ACTRN12609000529246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000529246.